pneumonia
sever
index
psi
import
score
system
assess
sever
commun
acquir
pneumonia
determin
admiss
statu
howev
lack
research
whether
score
system
appli
viral
commun
acquir
pneumonia
purpos
studi
evalu
use
psi
viral
commun
acquir
pneumonia
retrospect
cohort
studi
includ
adult
patient
age
year
admit
emerg
depart
univers
hospit
communityacquir
pneumonia
viral
infect
diagnos
multiplex
pcr
patient
diagnos
nonvir
communityacquir
pneumonia
includ
control
group
n
main
outcom
allcaus
mortal
multivari
cox
regress
analys
perform
calcul
risk
death
respiratori
virus
detect
patient
communityacquir
pneumonia
two
type
respiratori
virus
detect
case
case
detect
one
viru
influenza
influenza
b
rhinoviru
respiratori
syncyti
viru
metapneumoviru
parainfluenza
coronaviru
bocaviru
adenoviru
mortal
significantli
differ
patient
respiratori
viru
without
respiratori
viru
allcaus
mortal
rate
respect
p
mortal
rate
increas
increas
psi
score
without
respiratori
viral
infect
pulmonari
sever
index
significantli
associ
mortal
adjust
respiratori
viru
detect
hazard
ratio
confid
interv
pneumonia
sever
index
score
import
factor
assess
prognosi
patient
communityacquir
pneumonia
regardless
respiratori
viru
detect
virus
frequent
caus
commun
associ
pneumonia
cap
among
cap
outpati
treatment
mortal
rang
mortal
rate
hospit
patient
base
mortal
rate
tool
predict
sever
plo
cap
develop
activ
use
clinic
practic
howev
mortal
viral
cap
well
valid
pneumonia
sever
index
psi
well
known
prognosi
commun
acquir
pulmonari
diseas
influenc
pathogen
howev
comorbid
patient
sever
infect
time
diagnosi
regard
import
factor
prognosi
adult
viral
cap
report
mortal
mortal
rate
viral
cap
lower
patient
outpati
treatment
increas
patient
age
unlik
pediatr
patient
mani
adult
patient
multipl
comorbid
adult
patient
viral
cap
coexist
diseas
sever
infect
diagnosi
age
rather
caus
organ
signific
impact
prognosi
howev
mortal
viral
cap
well
consid
cofound
comorbid
adult
sinc
introduct
highli
sensit
viral
detect
method
polymeras
chain
reaction
pcr
incid
respiratori
virus
increas
communityacquir
pneumonia
develop
pcr
method
made
possibl
simultan
diagnos
multipl
respiratori
virus
use
one
sampl
develop
introduct
sensit
test
method
requir
period
confirm
viral
cap
epidemiolog
adjust
mortal
rate
establish
prognost
factor
aim
investig
distribut
pneumonia
sever
index
psi
class
whether
psi
play
role
prognost
factor
viral
cap
studi
allcaus
mortal
rate
hospit
admit
cap
patient
respiratori
virus
relat
pneumonia
sever
index
psi
retrospect
cohort
studi
hospit
adult
cap
patient
respiratori
viru
infect
conduct
patient
age
year
admit
januari
decemb
suspect
respiratori
viral
infect
n
studi
physician
suspect
respiratori
viral
ill
viru
multiplex
pcr
perform
exclud
subject
identifi
radiolog
pneumonia
find
fig
virus
detect
cap
patient
n
compar
patient
diagnos
virus
detect
cap
n
period
two
patient
mix
infect
bocaviru
parainfluenza
among
rsvinfect
patient
one
mix
infect
rhinoviru
one
patient
influenza
among
influenzainfect
patient
two
patient
mix
infect
bocaviru
patient
mix
infect
includ
studi
current
studi
approv
institut
review
board
irb
dongsan
hospit
keimyung
univers
school
medicin
irb
waiv
requir
inform
consent
studi
conduct
complianc
declar
helsinki
pneumonia
defin
presenc
new
progress
infiltr
found
use
either
chest
radiographi
chest
ct
scan
addit
two
follow
fever
sputum
product
rhinorrhea
sore
throat
dyspnea
diagnosi
pneumonia
attend
physician
outcom
design
allcaus
mortal
day
hospit
admiss
studi
period
nasopharyng
specimen
obtain
use
flock
swab
store
transport
use
univers
transport
medium
nobelbio
hwaseong
korea
nasopharyng
specimen
submit
respiratori
viru
detect
nucleic
acid
extract
specimen
use
viral
genespin
tm
viral
dnarna
extract
kit
intron
biotechnolog
seongnam
korea
cdna
synthes
extract
rna
sampl
cdna
synthesi
premix
seegen
kyseoul
korea
geneamp
pcr
system
thermal
cycler
appli
biomateri
foster
citi
ca
usa
blood
cultur
perform
everi
pneumonia
patient
sputum
cultur
perform
patient
expector
sputum
respiratori
viru
rv
test
perform
detect
follow
virus
adenoviru
af
influenza
virus
b
rsv
rsv
b
parainfluenza
virus
rhinoviru
metapneumoviru
coronaviru
coronaviru
bocaviru
test
intern
control
ad
specimen
check
entir
process
nucleic
acid
extract
pcr
accord
manufactur
instruct
anyplex
ii
detect
kit
biosewoom
seoul
korea
use
accord
manufactur
instruct
studi
perform
keimyung
univers
dongsan
hospit
tertiari
care
teach
hospit
daegu
republ
korea
patient
episod
acut
respiratori
infect
emerg
depart
outpati
clinic
within
day
admiss
underw
multiplex
rtpcr
test
adult
patient
year
age
underw
multiplex
rtpcr
test
januari
decemb
identifi
electron
medic
record
collect
clinic
data
use
electron
medic
record
gener
characterist
comorbid
present
symptom
lower
respiratori
complic
requir
supplement
oxygen
therapi
andor
ventilatori
support
hospit
durat
allcaus
mortal
chest
radiographi
perform
patient
admit
hospit
radiograph
interpret
perform
case
radiologist
chest
ct
scan
also
taken
case
among
cap
addit
laboratori
investig
perform
base
result
routin
blood
test
sputum
sampl
collect
bacteri
cultur
prepar
admiss
hospit
blood
cultur
also
perform
indic
pneumonia
sever
index
psi
consist
four
part
demograph
includ
age
sex
comorbid
physic
examin
laboratori
find
psi
score
collect
everi
admit
patient
contact
patient
famili
phone
identifi
surviv
clinic
inform
patient
follow
regularli
baselin
characterist
includ
age
sex
resid
longterm
care
facil
comorbid
present
symptom
complic
date
admiss
case
control
patient
summar
use
descript
statist
proport
mean
standard
deviat
sd
chisquar
test
appli
comparison
categor
variabl
twotail
ttest
comparison
continu
variabl
univari
multivari
cox
regress
model
use
evalu
risk
death
cap
analyz
surviv
curv
viru
detect
viru
detect
subject
kaplanmei
method
compar
use
logrank
test
multivari
cox
regress
perform
detect
viru
variabl
analyz
differ
mortal
accord
type
virus
p
valu
consid
statist
signific
statist
analys
perform
use
spss
ibm
armonk
ny
among
adult
patient
diagnos
hospit
cap
found
viral
etiolog
remain
viru
detect
tabl
show
basic
characterist
outcom
cap
patient
mean
age
group
patient
detect
viru
year
mean
age
group
patient
detect
viru
year
except
systol
blood
pressur
signific
differ
bodi
temperatur
puls
rate
respir
rate
virusdetect
viru
notdetect
patient
cap
laboratori
find
significantli
differ
virusdetect
viru
nondetect
cap
patient
bacteri
pathogen
detect
patient
sputum
rate
virusdetect
viru
nondetect
cap
patient
respect
detect
bacteria
blood
almost
two
group
vs
respect
measur
outcom
psi
score
mortal
mortal
significantli
differ
mortal
rate
analyz
accord
psi
score
tabl
mortal
rate
increas
increas
psi
score
group
virusdetect
cap
group
mortal
began
psi
class
iii
psi
contrast
class
iii
cap
patient
detect
viru
found
mortal
rate
signific
differ
mortal
either
group
outsid
psi
class
iii
multivari
analys
perform
determin
whether
detect
viru
cap
patient
affect
mortal
rate
day
psi
class
viru
detect
use
independ
variabl
multivari
analys
presenc
virus
affect
prognosi
psi
class
signific
effect
mortal
day
psi
class
observ
signific
variabl
associ
mortal
day
psi
class
v
mortal
rate
time
psi
class
tabl
psi
significantli
associ
mortal
adjust
respiratori
viru
detect
hazard
ratio
confid
interv
crude
mortal
virusdetect
viru
notdetect
cap
respect
p
fig
respiratori
virus
detect
patient
communityacquir
pneumonia
two
type
respiratori
virus
detect
case
case
detect
one
viru
influenza
influenza
b
rhinoviru
respiratori
syncyti
viru
metapneumoviru
parainfluenza
coronaviru
bocaviru
adenoviru
among
coinfect
patient
two
bocaviru
parainfluenza
one
bocaviru
influenza
one
bocaviru
influenza
b
one
rsv
rhinoviru
one
rsv
influenza
one
influenza
b
mortal
rate
day
accord
type
viru
analyz
seven
patient
two
virus
exclud
analysi
viru
type
signific
effect
allcaus
mortal
cap
fig
sputum
specimen
bloodcultur
specimen
obtain
pathogen
sputum
detect
patient
among
viru
detect
cap
gramposit
pathogen
detect
patient
gramneg
pathogen
pathogen
sputum
detect
patient
among
viru
detect
cap
gramposit
pathogen
detect
patient
gramneg
pathogen
pathogen
blood
detect
patient
among
viru
detect
cap
gramposit
pathogen
detect
patient
gramneg
pathogen
pathogen
blood
detect
patient
among
viru
detect
cap
gramposit
pathogen
detect
patient
gramneg
pathogen
regardless
respiratori
viru
infect
aureu
common
isol
pathogen
either
sputum
blood
tabl
psi
class
indic
mortal
higher
score
higher
mortal
rate
viral
nonvir
cap
tabl
psi
significantli
associ
mortal
adjust
respiratori
viru
detect
tabl
studi
show
presenc
viru
adult
cap
patient
affect
mortal
rate
compar
nonvir
cap
similar
previou
studi
virusdetect
cap
significantli
lower
psi
class
iii
group
viru
nondetect
cap
result
suggest
viral
infect
neglig
effect
prognosi
comorbid
small
clinic
featur
sever
although
signific
differ
hypothesi
support
absenc
mortal
virusdetect
cap
group
meet
psi
class
iii
tabl
patient
symptom
physic
exam
find
presenc
comorbid
suspect
signific
impact
prognosi
etiolog
cap
viral
infect
report
associ
prognosi
critic
ill
patient
studi
show
type
virus
signific
effect
prognosi
patient
cap
howev
hazard
ratio
parainfluenza
rsv
viru
infect
increas
ci
ci
compar
nonvir
cap
respect
fig
result
similar
previou
report
compar
prognosi
rsv
influenza
infect
spanish
flu
pneumonia
due
secondari
bacteri
infect
identifi
major
caus
death
infect
influenza
viru
frequenc
secondari
bacteri
infect
high
secondari
infect
gramposit
bacteria
increas
due
viral
endotheli
cell
damag
mechan
increas
concern
bacteremia
viral
infect
therefor
assum
set
respiratori
viru
infect
prognosi
might
affect
bacteri
infect
rate
posit
bacteri
respiratori
cultur
patient
virusdetect
viru
nondetect
cap
remain
studi
sputum
posit
bacteri
cultur
occur
patient
virusdetect
cap
similar
slightli
higher
previou
studi
frequenc
blood
stream
bacteri
infect
bacteremia
rate
differ
virusdetect
viru
nondetect
cap
studi
suggest
antibiot
could
consid
even
viral
infect
suspect
cap
among
cap
patient
approxim
found
viru
detect
rate
similar
slightli
lower
studi
frequenc
detect
respiratori
virus
rhinoviru
influenza
rsv
order
respect
result
similar
largescal
studi
known
frequenc
viral
cap
increas
age
lower
children
studi
mean
age
virusdetect
group
year
old
addit
age
rang
virusdetect
nonvirusdetect
group
similar
viral
respiratori
infect
import
age
societi
studi
sever
limit
first
absenc
viru
nasopharynx
exclud
presenc
viru
lower
respiratori
tract
thu
result
may
underestim
viral
etiolog
lower
respiratori
tract
infect
second
data
retrospect
collect
miss
data
inadequ
document
medic
start
time
may
result
studi
analysi
bia
third
need
valid
result
larger
number
hospit
limit
number
patient
result
small
sampl
size
mortal
rate
cap
significantli
increas
accord
psi
class
virusdetect
viru
nondetect
group
psi
class
crucial
factor
assess
prognosi
patient
cap
regardless
respiratori
viru
detect
support
inform
file
dataset
studi
xlsx
